Table 3.
Clinical Data on Previous and Current Treatment of Patients With SBP (n = 20)
Characteristics | N (%) |
---|---|
Previous antibiotic exposurea | 13 (65) |
Nonselective β-blockersa | 5 (25) |
Proton pump inhibitorsa | 18 (90) |
On rifaximin prophylaxis at SBP | 7 (35) |
Empirical treatment of SBP | |
Piperacillin/tazobactam ± linezolid | 11 (55) |
Meropenem + linezolid | 8 (40) |
Failure of empirical therapy | 4 (20) |
Within the last 4 weeks.